The Pfizer Foundation* announced today 20 grants to help non-governmental organizations (NGOs), non-profits and social enterprises address critical health challenges related to infectious diseases, including the increasing threat of antimicrobial resistance (AMR), in some of the world’s most vulnerable communities. Recipients of the one-year Global Health Innovation Grants (GHIG) include partners in 12 low- and middle-income countries that will each receive US $100,000, for a total investment this year of US $2 million by The Pfizer Foundation.
Following the G20, Joerg Reinhardt, Chairman of the Novartis Board of Directors, reflects on how to fight rising antimicrobial resistance
ZURICH, Switzerland, July 20, 2017/3BL Media/ – Two weeks ago, G20 leaders committed to working together to address one of the world’s most pressing and perplexing security threats: antimicrobial resistance (AMR) – a fierce and evolving adversary against which conventional therapeutic weapons are of no use.
Among the most notable findings from this year’s Strategic Directions: Water Industry Report is the velocity of planning throughout the industry for implementing more advanced operational technologies, such as advanced metering infrastructure (AMI) and enterprise asset management. More than 30 percent of utilities have indicated plans to implement these technologies, indicating the industry’s evolution and response to perennial issues of tightening budgets, rising costs and providing enhanced customer service.